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Abstract
Background: The high frequency of outpatient visits after kidney transplantation is burdensome to both the recovering patient
and health care capacity. Self-monitoring kidney function offers a promising strategy to reduce the number of these outpatient
visits.
Objective: The objective of this study was to investigate whether it is safe to rely on patients’ self-measurements of creatinine
and blood pressure, using data from a self-management randomized controlled trial.
Methods: For self-monitoring creatinine, each participant received a StatSensor Xpress-i Creatinine Meter and related test
material. For self-monitoring blood pressure, each participant received a Microlife WatchBP Home, an oscillometric device for
blood pressure self-measurement on the upper arm. Both devices had a memory function and the option to download stored values
to a computer. During the first year post transplantation, 54 patients registered their self-measured creatinine values in a Web-based
Self-Management Support System (SMSS) which provided automatic feedback on the registered values (eg, seek contact with
hospital). Values registered in the SMSS were compared with those logged automatically in the creatinine device to study reliability
of registered data. Adherence to measurement frequency was determined by comparing the number of requested with the number
of performed measurements. To study adherence to provided feedback, SMSS-logged feedback and information from the electronic
hospital files were analyzed.
Results: Level of adherence was highest during months 2-4 post transplantation with over 90% (42/47) of patients performing
at least 75% of the requested measurements. Overall, 87.00% (3448/3963) of all registered creatinine values were entered correctly,
although values were often registered several days later. If (the number of) measured and registered values deviated, the mean
of registered creatinine values was significantly lower than what was measured, suggesting active selection of lower creatinine
values. Adherence to SMSS feedback ranged from 53% (14/24) to 85% (33/39), depending on the specific feedback.
Conclusions: Patients’ tendency to postpone registration and to select lower creatinine values for registration and the suboptimal
adherence to the feedback provided by the SMSS might challenge safety. This should be well considered when designing
self-monitoring care systems, for example by ensuring that self-measured data are transferred automatically to an SMSS.
(J Med Internet Res 2017;19(9):e316)   doi:10.2196/jmir.7542
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Introduction
After kidney transplantation, an early detection of transplant
failure is mandatory to minimize permanent damage to the
transplanted organ. For kidneys, blood level of creatinine is
considered the most important indicator of kidney function [1].
Patients therefore have their serum creatinine checked on
average 20 times during the first year post transplantation. As
hypertension is both a potential indicator of decreased kidney
function and an important risk factor for kidney graft failure
[2-5], blood pressure needs extensive monitoring too. If patients
were enabled to monitor both parameters at home, this would
have important advantages. Self-monitoring could improve the
speed of rejection detection as measurements can take place
more frequently while at the same time the high number of
outpatient visits could be reduced and replaced by telephonic
consults. Furthermore, giving patients a more active role in their
own care through self-monitoring has been shown to be of
clinical benefit for a wide range of patients with chronic disease
[6-15] and to lead to a higher quality of life [16-19]and more
patient empowerment [7,19-22].
A pilot study of our own group showed that self-monitoring of
both blood pressure and creatinine is very well accepted among
patients, suggesting that at-home monitoring after transplantation
offers a promising strategy [23]. For self-monitoring to be a
safe alternative to regular face-to-face follow-up, however,
patients need to adhere to a monitoring schedule, report test
results accurately, and act upon test results if these suggest graft
failure may occur. This is important for all patients who engage
in self-monitoring, but especially for patients who are
transplanted. As most patients who develop graft rejection are
asymptomatic and present with an increased serum creatinine
only, frequent measuring is essential to make the difference
between treatment in time and damage to or even loss of the
kidney transplant. Level of adherence to a self-monitoring
schedule has been shown to vary widely in other disease
populations [24-28]. Further, for self-measured values to be
clinically useful, they need to be reported accurately. Several
studies in different study populations have shown that caution
is warranted when using patient-reported data for making clinical
decisions as a considerable number of patients report values
that do not sufficiently represent their actual measurements
[29-34].
To the best of our knowledge, no studies have assessed the
reliability and accuracy of patient-generated creatinine data or
looked at the level of adherence to a protocol of self-monitoring
creatinine. This is unfortunate, as the introduction of
self-monitoring offers a good opportunity to improve
post-transplantation care. Our first research goal was to
investigate the level of adherence of kidney transplant patients
to a creatinine monitoring schedule. Our second research goal
was to determine the reliability of the creatinine values that
were registered in a Web-based self-management support system
(SMSS). As this SMSS automatically provided instructions for
further actions (eg, continue regular schedule or contact the
hospital) upon registration of a new creatinine value, our final
research goal was to determine whether patients adhered to the
system’s instructions.
Methods
Patients and Study Design
The data used in this study were obtained from the ADMIRE
project (Assessment of a Disease management system with
Medical devices In REnal disease), a cooperation between the
Leiden University Medical Centre (LUMC), the Technical
University of Delft, and the Dutch Organization for Applied
Scientific Research (registered in the Dutch Trial Register:
NTR3548). This extensive project comprised the technical
development of an SMSS in which several studies were
performed to optimize the system to suit patients’ needs and
wishes, as well as a prospective randomized controlled trial
(RCT) to study whether self-monitoring kidney function
supported by an SMSS can replace part of regular outpatient
care without compromising on the quality of care. The study
protocol was approved by the Medical Ethics Committee of the
LUMC.
Patients were eligible for participation in the RCT if they were
about to receive a donor kidney or recently received one, were
≥18 years of age, mastered the Dutch language sufficiently, had
access to the Internet, and had a creatinine level of ≤300 µmol/l
within 4 weeks post transplantation. Patients were excluded if
they were visually impaired or were considered ineligible by
their treating physician (eg, due to mental retardation, a history
of noncompliance to treatment). We therefore had a selection
of patients that seemed most capable for engaging in
self-monitoring.
Recruitment of living donor recipients took place during a
pretransplant consultation with a nurse-practitioner. Recipients
of a postmortem kidney were recruited during their
post-transplantation stay in the hospital by the primary
investigator (CvL). After this face-to-face introduction, patients
received a written explanation of the study with an informed
consent form. If a signed informed consent was not returned
within 2 weeks from the recruitment date, patients were
contacted telephonically to inquire whether they were interested
in participating. After signing informed consent, each participant
was assigned a study number. Incoming informed consents were
treated in consecutive order. Study numbers were allocated to
either the intervention or the control group according to a preset
randomization schedule which was created by a medical
statistician. The randomization procedure was blinded for the
project members directly involved in patient recruitment.
For this study, only participants randomized to the intervention
group were included.
Intervention
Devices and Self-Management Support System
For self-monitoring creatinine, each participant received a
StatSensor Xpress-i Creatinine Meter (Nova Biomedical,
Waltham, USA) and related test material (ie, test strips, control
solution to test the quality of the strips, and safety lancets for
capillary blood sampling). On the basis of a drop of blood of
1.2 μL, the StatSensor can show either current level of creatinine
or estimated glomerular filtration rate (eGFR). At our medical
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center, clinicians usually communicate level of creatinine to
kidney transplant patients, and the device was set to show
creatinine.
For self-monitoring blood pressure, each participant received
a Microlife WatchBP Home (Microlife, Heerbrugg,
Switzerland), an oscillometric device for blood pressure
self-measurement on the upper arm. Both devices had a memory
function and the option to download stored values to a computer.
A Web-based SMSS was available for all patients in the
intervention group. This SMSS entailed an e-learning module
instructing patients on how to use the SMSS system, that is (a)
how to perform creatinine measurements at home, (b) how to
register self-measured values in the SMSS (both creatinine and
blood pressure), and (c) how to respond to messages from the
automatic feedback system to support patients’ interpretation
of the creatinine trends. Figure 1 provides an overview of the
feedback process. The feedback appeared directly after
registration of a new creatinine value and consisted of a traffic
light with corresponding text. Per day, a maximum of two
creatinine values could be registered. After registration of the
first value of the day, a green light indicated that there was no
reason for concern and was associated with the advice to just
continue regular measurement frequency. This was termed the
day conclusion, as no further actions were required for the
concerning day. The appearance of an orange or red light (in
case the newly registered value was respectively >15% or >20%
higher than mean of the previous five values) directly after
registration of the first value of the day indicated that there was
some reason for concern. The system’s advice was then to
perform and register a second measurement to confirm the first
measurement. This was termed action feedback, as it required
an immediate action. After registration of a second measurement,
an appearing green light indicated that there was no further
reason for concern. In this case, patients were advised to
continue their regular monitoring frequency. Alternatively, an
orange light indicated that there was some reason for concern
and patients were advised to measure again tomorrow. Finally,
a red light indicated that there was reason for concern and
patients were advised to contact the hospital. Feedback given
after the registration of a second measurement was also termed
day conclusion, as no further values could be registered. See
Figure 1 for an overview of all possible feedback combinations.
A link was created between the SMSS and the electronic hospital
system in order for the registered creatinine values to be visible
for the treating nephrologist(s). Nephrologists did not receive
a copy of the supplied SMSS feedback.
Figure 1. Possible feedback combinations in the Self-Management Support System (SMSS).
Procedure
The time schedule for providing instructions depended on
whether patients participated in the living donor program or
whether they received a kidney from a deceased donor. Two
weeks before a scheduled transplantation, patients received
account details to log in to the SMSS and use the e-learning
module to prepare for self-monitoring. Recipients of a kidney
from a deceased donor received account details during their
post-transplantation stay in the hospital. A laptop was available
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to use the e-learning modules. After being virtually instructed
through e-learning, all patients received the creatinine device
and supplementary face-to-face instructions. Special attention
was paid to the fact that patients had to take action themselves
upon the system’s feedback, as their nephrologist(s) would only
check the home-based creatinine values in advance of or during
an outpatient visit or a telephonic consult. Patients were then
encouraged to practice using the creatinine device during the
remainder of their hospital stay.
Home-based creatinine measurements had to be performed
according to a fixed frequency, being daily during the first 4
weeks (phase 1), every other day for weeks 5-9 (phase 2), twice
a week for weeks 10-15 (phase 3), and weekly from week 16
onward (phase 4). This scheme was based upon the usual
frequency of laboratory testing, which decreases when time
since transplantation increases. However, as the creatinine device
tends to be less accurate than laboratory tests [35], the usual
frequency of laboratory testing was multiplied with a factor 7
to obtain a more reliable trend. After measuring, patients
registered the results in the SMSS.
In addition to conducting regular creatinine measurements,
patients were advised to perform a test measurement when
opening a new bottle of test strips. These measurements could
be termed test measurements by pressing a designated button
on the creatinine device.
From week 8 after transplantation on, every other face-to-face
outpatient visit with regular hospital-based laboratory
measurements was replaced by a telephonic consult to discuss
self-monitored creatinine and blood pressure. Although regular
face-to-face visits also include other laboratory measurements
(eg, trough levels of immunosuppressive medication), these
analyses do not need to be performed in the same frequency as
for creatinine due to their (expected) little variation over a short
period of time. It was therefore deemed unnecessary to replace
these other laboratory measurements with a home-based
alternative.
To remind nephrologists of scheduling a telephone consult
instead of a face-to-face visit, a short note asking for the next
appointment to be a telephonic one was shown repetitively in
a patient’s electronic hospital file. It was, however, up to the
treating nephrologist to judge whether a patient’s condition
allowed for a telephonic consult to take place or whether a
face-to-face visit was needed.
At the end of the intervention period of one year, all patients
were invited to bring their creatinine device to download logged
data. This data included test results, date and time of all
performed measurements, and, if applicable, an indication of
whether a specific value was termed a test measurement. Further,
data that were automatically logged in the SMSS were
downloaded including the registered value(s), date of performed
measurement (according to the patient), date of registration, and
the feedback that was supplied after each newly registered
creatinine value.
Measures
Patients completed a questionnaire at baseline to collect
demographic characteristics. The read-out data from the
creatinine device and the data that were logged in the SMSS
were combined using date of measurement. For the creatinine
device, measurement date was the date of measurement
performance that was registered automatically in the device
memory. For the SMSS, measurement date was the date of
measurement performance according to the patient.
Statistical Analyses
Adherence to Measurement Frequency
To assess whether patients adhered to the measurement protocol,
we separated adherence according to device-logged data (did
patients perform the requested number of measurements?) and
adherence to SMSS-logged data (did patients register the
requested number of measurements in the SMSS?). If applicable,
paired t tests were conducted to compare means using SPSS
22.0 for Windows (IBM Corp, Armonk, NY). In these cases
P<.05 was considered statistically significant. For adherence
according to device-logged data, we calculated the number of
days with measurements per patient per phase and compared
this with the number of requested measurement days. Number
of requested measurement days was 28 during phase 1 (4
weeks), 15 during phase 2 (5 weeks), 12 during phase 3 (6
weeks), and 37 during phase 4 (37 weeks). To make it easier to
interpret the results, level of adherence was divided in four
subcategories for this study:
1. Extremely nonadherent: measurements performed during
less than 25% of the requested days
2. Nonadherent: measurements performed during 25-74% of
the requested measurement days
3. Adherent: measurements performed during 75-100% of the
requested measurement days
4. Overadherent: measurements performed more frequently
than requested (ie, > 100%).
This same procedure was used to calculate the level of adherence
to registration of measurement in the SMSS, that is, whether
patients registered measurements on the requested number of
days.
Moment of Registration
Date of measurement (derived from device-logged data) was
compared with the date of registration of this measurement
(derived from SMSS-logged data). Per patient the average
number of days delay between measurement and registration
was calculated. Furthermore, we investigated whether delayed
registration was related to the stability of creatinine level by
comparing feedback that was generated by the SMSS in case
of registration on day of measurement with feedback that was
generated when registration was delayed.
Reliability: Correctness and Representativeness of
Registered Data
The reliability of registered data is determined by both the
correctness and the representativeness of registered values. To
study correctness of the registered data, we investigated the
one-on-one correspondence between registered and measured
values on a given day. Three different categories were
distinguished:
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1. Reliable SMSS registrations, in case a value that was
registered in the SMSS corresponded to the device logged
value on a given date. Only days with an equal number of
measurements logged in the device and SMSS were taken
into account.
2. Noncorrespondence, in case an SMSS registered value did
not correspond to the device-logged value on a given date.
Only days with an equal number of measurements in the
device-logged and SMSS-logged data were selected. All
cases of noncorrespondence were carefully checked for
potential causes of the deviance (eg, wrong combination of
date and measured value, typo, rounding off). The cases
where no potential cause was found were termed incorrect
entries. For each patient, a mean level of creatinine was
calculated for the values that were actually measured and
for the values that were registered using cases of incorrect
entry only. A paired t test was performed to compare these
means. Total and median number of noncorresponding
values was calculated per patient. Patients with a high
number of noncorresponding values were selected for
further exploration.
3. Phantom values, in case a value was registered in the SMSS
on a given date while according to the data stored in the
device no measurement was performed on that specific date.
All potential phantom values were thoroughly checked for
alternative explanations before it was concluded that there
was no relation with values that had been measured by the
patient. A paired t test was performed using the mean of
the phantom values versus the mean of all measured
creatinine values per patient.
Furthermore, to get a reliable impression of a creatinine level
over time (trend), the SMSS registered values need to represent
what was actually measured. It is therefore important to know
how often a measured value was not registered in the SMSS
and whether the unregistered values differed in any way from
the registered values. The measured values not being registered
in the SMSS were split into two categories:
1. Omissions, in case one or more measurements were
performed on a given date, but no value was registered in
the SMSS. Total and median number of omissions per
patient was calculated. For each patient, we calculated a
mean level of creatinine for the values that were both
measured and registered and a mean level of creatinine for
the values that were measured on days without any
registration. A paired t test was performed to compare these
means.
2. Selection of measurements, which is the case when the
number of performed measurements that is stored in the
device is higher than the number of registered measurements
on a given date. Therefore only days with a difference
between the number of measured and the number of
registered creatinine values were selected (eg, three
measurements stored in the device and one value registered
in the SMSS). We then calculated per patient the mean of
all values stored in the device and registered in the SMSS
and the mean of all values stored in the device, but not
registered in the SMSS. A paired t test was performed to
compare these means.
Adherence to Feedback
After registration of a creatinine value in the SMSS, patients
received an automatically generated advice on the necessary
action to take (see Figure 1). To investigate the level of
adherence to the advice generated by the SMSS, we separated
between adherence to action feedback (supplied after the
registration of a first measurement when further action was
required) and adherence to the day conclusion (supplied when
no further actions were required after the first registration of a
day or when a second and final measurement was registered on
the same day).
Action feedback could only appear in case the newly registered
creatinine value was higher than the previous ones and required
an additional measurement to confirm the first. In these cases,
the feedback system of the SMSS showed an orange or red
traffic light with the corresponding advice to repeat the
measurement. From the SMSS-logged data, we selected those
cases where a second measurement was requested and checked
whether the concerning patients indeed measured and registered
a second creatinine value on the same day.
To study adherence to the day conclusion, we only considered
the cases in which patients again were confronted with an orange
or a red traffic light. In case of a request to perform another
measurement the next day (orange traffic light), the
SMSS-logged data were checked to see whether the requested
action was indeed performed. In case of a request to contact the
hospital (red traffic light), patient hospital records were searched
for telephonic and outpatient contacts on dates following the
concerning feedback.
Sensitivity Analyses
Two sensitivity analyses were performed to control for potential
bias. First, as being hospitalized limits the possibility to keep
up with requested measurement and registration frequency, the
level of adherence was analyzed with and without patients that
were hospitalized during the study. The second sensitivity
analysis concerned the test measurements patients were
requested to perform when opening a new bottle of strips. Many
patients either did not perform test measurements or did not
indicate them as such. To prevent test values to be mistakenly
considered creatinine measurements, all values that were stored
in the device memory were checked. Potential test values were
discussed and decided upon by the two main authors. The
following criteria were used: (1) the value was not registered
in the SMSS, (2) the value differed from the previous and
following value, (3) the value fell within the test value range
that was set by the manufacturer (133-239 µmol/l), and (4) the
value followed or was followed by at least one SMSS-registered
value measured on that same day (measured shortly after one
another according to device-logged data). After having
thoroughly checked and discussed all potential test values, for
24 values it remained unclear whether they were test values or
not. We therefore performed all analyses concerning the
representativeness of registered creatinine data with and without
these 24 values.
Furthermore, we compared our findings concerning patient
self-monitoring creatinine to a more broadly used and
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well-accepted form of patient monitoring, being self-monitoring
of blood pressure. For this purpose, we performed two analyses
with the self-monitored and self-reported blood pressure
measurements in our study population. First, we looked at
adherence to the blood pressure measurement protocol using
the same procedure as for creatinine: number of days with
measurements versus number of requested measurement days
per patient per phase. The requested frequency of blood pressure
measurements was equal to the measurement frequency of
creatinine. As many patients used other blood pressure devices
than the device we supplied for the study, we could not
determine adherence to the measurement protocol in a reliable
way. We therefore only could assess adherence to the
registration protocol by comparing the number of registered
blood pressure measurements (SMSS-logged data) with the
requested measurement frequency.
Second, we looked at correspondence between measured and
registered blood pressures. To prevent potential bias and
misinterpretation, we (1) only used measurements from days
with an equal number of measurements and registrations and
(2) calculated a mean arterial pressure (MAP,
[(2×diastolic)+systolic]/3) for both measured and registered
blood pressures per day. Using all cases of noncorrespondence
between measured and registered MAP, an overall MAP was
calculated per patient for both blood pressures that were actually
measured and for blood pressures that were registered in the
SMSS. A paired t test was performed comparing these means.
Results
Participants
Within the period of inclusion, in total 217 patients received a
kidney transplant of which 155 were considered eligible for
participation. The main reasons for ineligibility were insufficient
mastery of the Dutch language (25/62, 40%) and no access to
a computer or limited computer skills (16/62, 26%). In total,
119 patients (76.7%) signed an informed consent. The main
reason for not wanting to participate was the anticipated burden
of self-monitoring (17/36, 47%). A total of 65 patients were
randomized to the intervention group. After randomization, 3
patients dropped out because of graft dysfunction, death, and
cancellation of transplantation (none was study related). Before
starting to self-monitor kidney function at home, 4 patients
canceled their participation because they reported having little
trust in the creatinine device, experienced difficulties when
logging into the SMSS, experienced business rush, or had a
worsened condition post transplantation. In total, 58 patients
were supplied with a creatinine and blood pressure device of
which 4 never performed any measurement.
Table 1. Baseline patient characteristics.
PUsed devices and SMSS during all phases
(n=43)
Received devices
(n=58)
Characteristicsa
P>.9927 (63)37 (64)Sex, male, n (%)
P=.4052.5 (15)51.6 (14)Age at transplantation, mean (SD)
P=.5033 (77)43 (74)Living together or married, n (%)
P=.7629 (67)39 (67)Children, yes, n (%)
P=.25Educational level, n (%)
14 (33)22 (38)Low
12 (28)16 (28)Middle
17 (39)20 (34)High
P>.9923 (53)31 (53)Paid job, yes, n (%)
P=.1041 (95)53 (91)Origin, native, n (%)
P=.644 (9.3)6 (10.3)Former transplantation, n (%)
P=.1421 (49)26 (44.8)Dialysis dependence before transplantation, n (%)
P=.5238 (89)50 (86.2)Living transplantation, n (%)
P=.3450 (15)49 (16.1)Kidney function (eGFR), mean (SD)
aFor a few patients, data on marital status and education were missing. These data were imputed in SPSS using multiple imputation (10 imputations).
To study the level of adherence to requested measurement
frequency, we included patients of whom measured values were
available for at least one complete study phase (N=48). To study
the reliability of registered data and adherence to system
feedback, we included patients who performed and registered
measurements during all study phases (N=43). The flowchart
in Figure 2 gives a stepwise overview of the patient flow and
for which selection of patients a specific analysis was performed.
Patient characteristics are shown in Table 1. The mean age of
participants was 52 and 53 years for patients who received the
monitoring devices (N=58) and patients who performed and
registered measurements during all study phases (N=43),
respectively. The number of patients with both a low and a high
educational level was slightly higher than in the average Dutch
population [36]. Almost 90% of our participants (50/58) had
received a kidney from a living donor, while the ratio of
transplantations with living versus postmortem kidneys was
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about equal in our center during the period of inclusion. This
discrepancy is mainly due to a higher percentage of ineligibility
among recipients of a postmortem versus living kidney: 51%
versus 16%, respectively.
Figure 2. Study flowchart.
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Figure 3. Patient adherence to requested measurement and Self-Management Support System (SMSS) registration frequency per study phase. The
x-axis refers to the different measurement frequencies requested throughout the study for both performed and registered measurements (daily, every
other day, twice a week, and weekly in phases 1, 2, 3, and 4, respectively), and the y-axis shows the percentage of adherent and overadherent and
nonadherent and extremely nonadherent patients.
Figure 4. Reliability of creatinine values registered in the disease management system. The unregistered (1291) and registered values (4606) do not
add up to the total number of measurements in the device (5804) due to the presence of phantom values.
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No differences were found between patients who received the
monitoring devices and patients who performed and registered
measurements during all study phases for the characteristics we
measured at baseline (see Table 1).
Adherence to Requested Measurement Frequency
Adherence to requested measurement frequency according to
device-logged data (did patients perform the requested number
of measurements?) and adherence to SMSS-logged data (if
patients performed a measured, did they register the requested
number of measurements?) are shown in Figure 3. During phase
1 (daily measurements), adherence to the requested number of
creatinine measurements was lowest with 75% (36/48).
Subsequently, adherence rose to over 90% during phases 2
(46/47, measuring every other day) and 3 (43/46, measuring
twice a week), and then decreased to 85% during phase 4 (39/46,
measuring weekly). In total, 4 patients performed less than 75%
of the requested measurements throughout two or more phases.
For registration of the requested number of creatinine
measurements this same pattern is shown, although the
percentage of nonadherent patients is higher during all phases.
In total, 8 patients were nonadherent during two or more phases
regarding registration of the requested number of measurements.
To control for the potential influence of hospitalization on the
level of adherence to measurement and registration protocol,
we repeated our analysis with all hospitalized patients excluded.
The total number of hospitalized patients was 11 during phase
1, 3 during phase 2, 7 during phase 3, and 9 during phase 4.
Excluding these patients did not change our initial findings.
Moment of Registration
When looking at the date of measurement versus the date of
registration of measurements, a mean delay of 4 days (SD 10)
was found. The level of delay varied from 1 to 81 days. A total
of 7 patients (7/47, 15%) always registered their test results on
the day of measurement and 15 patients (31%) had an overall
mean delay of less than 1 day between measurement and
registration. In total, 22 patients (46%) had an overall mean
delay of more than 3 days, ranging up to a mean difference of
29 days between the date of measurement and the date of
registration. One could hypothesize that patients do not feel the
need to register their measurement if their level of creatinine is
stable. However, the feedback that was generated by the SMSS
for measurements registered on the day of measurement versus
measurements that were registered with delay did not differ: in
both situations, patients were requested to repeat the
measurement in about 7% of all registrations.
The x-axis refers to the different measurement frequencies
requested throughout the study for both performed and registered
measurements (daily, every other day, twice a week, and weekly
in phases 1, 2, 3, and 4, respectively), and the y-axis shows the
percentage of adherent and overadherent and nonadherent and
extremely nonadherent patients.
Reliability of Registered Data
Of the 43 patients included in the reliability analysis, the total
number of values stored in the creatinine devices was 5779 and
the total number of values registered in the SMSS was 4606.
To investigate correspondence between measurement and
registration, only days with an equal number of measurements
in the device and registrations in the SMSS were selected. Total
number of measurements performed and registered on these
days was 3963. Figure 4 gives an overview of the reliability of
the registered data, showing that 3448 (87.00%) of these values
were registered correctly.
Noncorresponding Registrations
In 13% (515/3963) of all creatinine registrations, the registered
value did not correspond to the value that was measured on that
day. In 174 cases, we could determine the origin of the
difference (eg, wrong combination of date and measured value,
typo, rounding off). The remaining 341 registrations (9% of all
registered values) were used for further analysis. Median number
of noncorresponding values per patient was 3 (Interquartile
range, IQR 8). Overall, 11 out of 43 patients (25%) made no
mistakes at all, while another 11 patients made more than 10
mistakes. In total, 2 patients had an extremely high number of
noncorresponding registrations. The first one had 52
noncorresponding registrations, half of which were found to be
exactly 10, 20, 30, or 40 µmol/l lower than what was actually
measured. In total, 83% (43/52) of his noncorresponding entries
were lower than what was measured. The other patient registered
92 noncorresponding values, which were lower than the actual
measured values in 93% (86/92) of his cases.
In case of noncorrespondence, the difference between measured
and registered ranged from 1 to 73 mmol/l with a median of 9
mmol/l (IQR 13). The noncorresponding registrations were
significantly lower than the actual measured ones: 123 mmol/l
(SD 28) versus 130 mmol (SD 33), respectively (t340=8.7,
P≤.001).
Phantom Values
In total, 93 phantom values were found, which was 2.02% of
all registered values (N=4606). In total, 30% of patient (13/43)
registered at least one phantom value, 14% (6/43) registered
seven or more. Of the phantom values, 20 resembled the
measurements of surrounding days, which would suggest these
phantom values were only registered to adhere to the registration
protocol. However, this appeared not to be the case as 16 of
these 20 resembling phantom values were registered by a single
patient who would already have been overly adherent without
these phantom values. Overall, 3 patients registered creatinine
values during the months where no measurements were logged
in the device. For example, one patient quit measuring in
February, but registered three measurements during March and
April. Phantom values were significantly lower than actually
measured ones, respectively 107 (SD 26) and 123 (15) mmol/l
(t11=3.9, P=.003).
Representation of Registered Creatinine Values
Of the 5779 measurements found in the creatinine device-logged
data, 1300 values (22.49%) were not registered in the SMSS.
In 700 cases, one or more measurements were performed on a
given date, but no value was registered in the SMSS (ie,
omission). Number of omissions per patient ranged from 0 to
145; 5 patients had no omissions at all and 11 patients had
omitted 20 values or more. Median number of omissions was
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8. The omitted values were significantly higher than the
registered ones (mean of 139 [SD 31] vs 130 [SD 32] µmol/l,
respectively (t42=−3.8, P ≤.001).
In several cases, more measurements were performed per day
than values were registered. In these so-called measurement
series, the number of performed measurements ranged from 2
to 8 with a median of 2 (IQR 1) per day. The total number of
values that was measured within a series of measurements but
was not registered in the SMSS was 600. The mean of the
creatinine values that were both stored in the device and
registered in the SMSS was significantly lower than the mean
of the creatinine values that were stored in the device but not
registered in the SMSS (unselected for registration): 137 (SD
35) vs 143 µmol/l (SD 36), respectively (t42=−2.5, P=.02).
Repeating both analyses with the 24 values included that could
either be test values or regular measurements did not change
our findings (data not shown).
Adherence to System Feedback
Results are given separately for adherence to the action code
(requesting patients to perform a second measurement directly)
and adherence to the day conclusion (feedback that only
appeared in case a second measurement was requested and
registered). An overview of the feedback procedure and level
of adherence to the different kinds of feedback is shown in
Figure 5.
Adherence to Action Code
In 258 cases, patients were requested to perform a second
measurement directly. In 137 cases (53%), patients actually
performed and registered a second measurement. In 85 cases
(33%), date of registration differed from the date of
measurement, suggesting that delayed registration was the main
reason for not adhering to feedback, as this feedback was no
longer up-to-date when shown to the patient. In 14 cases (5%),
multiple measurements were performed in advance of
registration. As these multiple measurements were probably
representative of actual creatinine level already, patients might
not have felt the need to perform another one.
Figure 5. Patient adherence to system feedback.
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Adherence to Day Conclusion
In 39 cases, patients were requested to measure again the next
day. In 33 cases (85%), this feedback was adhered to. In 3 cases
(8%), the measurements were registered several days after
measurement (delayed registration), suggesting that the feedback
to measure again the next day was no longer up-to-date when
shown to these patients. In one case, the requested measurement
was performed, but was not registered in the SMSS.
The advice to contact the hospital was given 24 times, which
was followed up 14 times (58%). In the remaining 10 cases
(concerning 10 individual patients), measurements were
registered with several days’ delay. As feedback was no longer
up-to-date when shown to the concerning patients, this suggests
delayed registration was the main reason for not adhering to the
feedback to contact the hospital. If only cases with registration
on the day of measurement were taken into account, adherence
to contacting the hospital was 100%.
Sensitivity Analysis: Adherence to and Reliability of
Blood Pressure Measurements
In total, 31 blood pressure devices could be read out. The total
number of values found in the 31 available pressure devices
was 4917, and the total number of values registered in the SMSS
was 5637. The higher number of registered than measured blood
pressures is due to patients using multiple blood pressure devices
during study participation, while data of only one device were
available. Adherence to registration of blood pressure
measurements was comparable to creatinine registrations with
70% (34/48), 88% (41/47), 87% (40/46), and 81% (37/46) of
patients registering >75% of the requested number of
measurements during phases 1, 2, 3, and 4, respectively.
Although the percentage of registrations not corresponding to
the measured MAP was comparable to what we found for
creatinine (14% vs 13%, respectively), we could not replicate
the significant difference between registered and actually
measured creatinine for blood pressure: 97 mmHg (SD 2) versus
96 mmHg (SD 9) for registered and measured MAPs,
respectively (t3=.20, P=.84).
Discussion
Principal Findings
Self-monitoring kidney function and blood pressure at home
offers important advantages for patients after kidney
transplantation. However, the value and safety of self-monitoring
depend on how well patients actually adhere to their
self-monitoring tasks, the reliability of the test results they
report, and whether they take appropriate actions based on their
measurements. This study showed that the level of adherence
was generally good. Well above 90% of all patients performed
the requested number of measurements during months 2-4 post
transplantation. Adherence was lower during the first month
when more measurements were requested and during months
5-12 post transplantation when less measurements were
requested, with about 75% and 85% of patients adhering to the
requested number of measurements, respectively. Overall
adherence to registration of measurements was about 10% lower
than adherence to performance of measurements during all
phases. Two studies reporting on the level of adherence to
monitoring vital signs after lung transplantation found similar
percentages of adherence being above 80% for the entire study
period [24,26]. For self-monitoring blood pressure, patients
with uncontrolled hypertension were shown to be adherent for
about 73% of the entire study period [25,29]. In both studies,
level of adherence was highest in the first few weeks and
declined gradually over time. In sum, mean level of adherence
that has been found in this study corresponds to percentages
that have previously been reported. In contrast, we did not find
the highest levels of adherence in the first period. This may
have been due to a strenuous measurement protocol. Patients
had to measure every day in the first month. In these first weeks
when patients have to recover and have to get used to life post
transplantation, performing measurements in such a high
frequency might be too burdensome. Furthermore, in this first
period, face-to-face visits were not yet replaced by telephonic
consults and patients therefore visited the hospital at least
weekly to monitor early signs of graft failure. Due to this high
frequency of visits, patients may have felt a reduced need to
perform measurements at home, as they did not have to rely on
these measurements. The latter may also be an explanation for
nonadherence during the whole study period.
Furthermore, for self-monitoring to be a safe alternative to
regular face-to-face follow up, patient-reported test results need
to be accurate. In this study, approximately 90% of both
creatinine and blood pressure measurements were registered
correctly in the SMSS. This percentage corresponds to what
has previously been described for patient-reported blood
pressure [29,37] and anticoagulation [34] and is much higher
than has been observed for patient-reported levels of blood
glucose. A study by Kalergis and colleagues [30], for example,
showed that slightly over half of the total group of patients with
either diabetes type 1 or 2 was considered very reliable in their
reporting. For patients with diabetes type 2 and for pregnant
women self-monitoring blood glucose, some studies even
showed that the majority of patient-reported data was unreliable
[31,32].
In cases of noncorrespondence between measured and actually
registered values, values that were eventually registered in the
SMSS were significantly lower than those actually measured.
These results seem to suggest that patients select, alter, or add
values in such a way that their creatinine profile looks more
positive. This corresponds to what has been found in a
population of patients with thrombosis, where the percentage
of time when patients’ level of anticoagulation was within the
desired range was significantly higher when using
patient-reported data compared with data stored in the device
[34]. For patients with diabetes or hypertension, it was found
that inaccurate reporting increased with increasing levels of
blood glucose [31] or blood pressure [37]. Why patients report
values that look better than the actual measured values or add
nonexistent measurements has not yet been fully clarified. For
diabetes, it has been suggested that patients report false glucose
levels due to a feeling of guilt for not having achieved glycemic
goals [32] or add phantoms values in an attempt to fill up
logbooks and satisfy their health care providers [30]. Both
situations seem to represent an attempt to be a “good” patient.
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However, altering and selecting data that are not representative
of the actual clinical situation or adding phantom values in any
case may be dangerous. This can lead to suboptimal treatment
and, eventually, to worsened patient outcomes [30,37]. In a
study by Kendrick and colleagues, it was found indeed that
women with pregnancy-derived diabetes received suboptimal
treatment due to a large difference between their reported
glucose values and what they had measured [32]. Results of
another study showed that diabetic patients who were more
reliable in their reporting had a significantly better glycemic
control. It was suggested that this may be due to the ability of
clinicians to adjust therapy more precisely if measurements are
reported accurately [30]. To prevent incorrect reporting, it has
been recommended to rely on the memory capacity of
measurement devices, preferably by using devices that can
transfer data automatically [30,31,33,34].
Besides eliminating the occurrence of both intentional and
unintentional errors, the automatic transfer of data offers a
solution for the observation that patients seem to save up their
measurements before registering them. Many patients saved up
their measurements over several days or even weeks to register
them all at once. More than one-third of our participants
displayed a mean delay of 5 or more days between measurement
and registration of data. This is alarming as frequent monitoring
and taking immediate action in case of early signs of graft failure
is vital to prevent or diminish damage to the kidney transplant.
An explanation for saving up measurements before registering
them might be that the measured creatinine values remained
stable. However, patients seemed to postpone registration
regardless of the stability of their kidney function. Indeed,
postponement of registration appeared to be the main reason
why patients had not followed up the advice to contact the
hospital when creatinine levels had alarmingly increased by
over 15%. Patients’ perception of these significant increases
could have been influenced by the fact that the innovative device
that was used during this study tended to be less accurate than
hospital laboratory measurements [35]. As a consequence,
patients might have been inclined to attribute sudden increases
in level of creatinine to a technical imprecision of the device.
Strengths and Limitations
To the best of our knowledge, this is the first study to assess
adherence to a protocol of self-monitoring creatinine and to
investigate the accuracy and reliability of patient-generated
creatinine data. Enabling patients to self-monitor kidney function
at home would have important advantages, especially for
patients living in remote areas. There are, however, some
limitations that must be considered when interpreting our
findings. First, the study was conducted at a single institute. As
each hospital has its own way of delivering care, results might
be different when conducted in other institutions. Our findings
do, however, resemble what has previously been found in other
disease populations. Second, participation in this study was
voluntary and we selected patients with access to the Internet.
Therefore, it is possible that our patients had an above-average
motivation to self-monitor. It is therefore likely that the current
findings provide a conservative estimate of the true incidence
of nonadherence and inaccuracy. In line with this, patients
reported very strong intentions to engage in self-monitoring
both at the start and after 4 months into the trial [38]. Their
intention was found to be especially associated with their overall
affective reaction toward using the system [38]. A considerable
number of eligible patients had to be contacted to inform
whether they were interested in study participation instead of
giving informed consent immediately. However, the limited
variance found in the level of intention to engage in
self-monitoring suggests that patients who had to be contacted
were not more hesitant to engage in self-monitoring than patients
who provided immediate informed consent.
Finally, the way adherence and nonadherence were determined
is arbitrary to some extent. As the importance of frequent and
very frequent monitoring differs per subpopulation and
parameter of interest, no gold standard for what can be
considered adherent is available. High blood pressure, for
example, needs to be present over a longer period of time before
becoming detrimental, while an increasing level of creatinine
can be indicative of a rejection episode, leading to irreversible
damage or even loss of the transplanted kidney if not quickly
noticed.
Implications
This study shows that the level of adherence to a protocol of
self-monitoring creatinine in the first year after kidney
transplantation was generally good, although adherence declined
over time. In addition, our results suggest that measuring every
day in the first period after transplantation might be too
burdensome. Furthermore, 90% of data were shown to be
accurately reported. In line with previous findings, however,
several patients reported more favorable data than they actually
measured. This suggests that some patients might be inclined
to select more favorable values for registration, which could
leave early signs of graft failure unnoticed. Additionally, the
majority of patients did not register their measured values on
the day of measurement, but saved up measurements over
several days to register them all at once. This so-called delayed
registration was the main reason for patients not having followed
up the advice to contact the hospital in case of a significantly
increased level of creatinine.
This study is part of a larger project in which the safety and
usability of self-monitoring kidney function after transplantation
supported by an SMSS are investigated. Our results showing
that patients seem inclined to select more favorable creatinine
values for registration and to postpone registration suggest a
challenge to the safety of self-monitoring. This should be well
considered when designing self-monitoring care systems, for
example by ensuring that self-measured data are transferred
automatically to an SMSS. Using devices that can transfer data
automatically and providing active feedback to patients (eg, by
sending text messages or emails) instead of having patients to
log on to a website will eliminate the issues of data selection
and delayed registration, and as such contribute to the safety of
self-monitoring kidney function after transplantation.
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